Wistar Scientists De
Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
June 04, 2024 10:50 ET | The Wistar Institute
PHILADELPHIA, PA, June 04, 2024 (GLOBE NEWSWIRE) -- Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only...
AVEO_LG Chem_Logo(Hi-Resolution).jpg
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 28, 2024 15:22 ET | AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned...
AVEO_LG Chem_Logo(Hi-Resolution).jpg
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
March 25, 2024 08:10 ET | AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...
Global Interventional Oncology Market
Global Interventional Oncology Market Anticipates Explosive Growth, Forecasted at $8.06 Billion by 2034 - Regional Insights for Products, Cancer Types, and End-users
March 12, 2024 12:39 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
AVEO_LG Chem_Logo(Hi-Resolution).jpg
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
February 06, 2024 08:10 ET | AVEO Pharmaceuticals, Inc.
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib
22157.jpg
Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
January 22, 2024 21:28 ET | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
MnM_logo_TM_JPG.JPG
Interventional Oncology Market is Expected to Reach $2.9 billion | MarketsandMarkets.
April 12, 2023 09:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, April 12, 2023 (GLOBE NEWSWIRE) -- The interventional oncology industry is expected to experience significant growth in the coming years, as new technologies and treatments are developed...
22157.jpg
Global Interventional Oncology Devices Market Report 2023: Players Include Boston Scientific, Medtronic, Terumo, and Philips Volcano
March 30, 2023 10:18 ET | Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Academic Urology Research Investigators Consortium
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
January 26, 2023 09:30 ET | Criterium Inc.
SARATOGA SPRINGS, N.Y., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Criterium, Inc., a full-service Contract Research Organization (CRO), is pleased to announce AURIC (Academic Urology Research Investigators...
interventional-oncology-market-size.jpg
The Worldwide Interventional Oncology Industry is Expected to Reach $2.9 Billion by 2028
November 24, 2022 08:08 ET | Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type (Liver Cancer, Lung Cancer, Kidney Cancer,...